By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Medicines360 

353 Sacramento Street
Suite 900
San Francisco  California  94111  U.S.A.
Phone: 415-403-8968 Fax: 415-951-8701


SEARCH JOBS








Company News
Medicines360 And Allergan (AGN) Announce Study Publication Evaluating Pelvic Infection Risk Following Same-Day Sexually Transmitted Infection Testing And Liletta (Levonorgestrel-Releasing Intrauterine System) 52 Mg Placement 11/16/2016 7:55:35 AM
Medicines360 And Population Services International Announce New Partnership To Expand Access To Hormonal IUDs To Women In Africa 9/28/2016 10:24:41 AM
Allergan (AGN) And Medicines360 Announce Launch Of New LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 Mg Single-Handed Inserter 9/14/2016 7:15:50 AM
Medicines360 And Allergan (AGN) Announce Publication Of Levonorgestrel Release Rates Over Five Years With The LILETTA 52 Mg Intrauterine System In 'Contraception' 9/7/2016 9:15:51 AM
Allergan (AGN) And Medicines360 Announce Donation Of Intrauterine Devices (IUD) To The CDC Foundation To Help Address Microcephaly Impact From Zika Virus In Puerto Rico 6/1/2016 9:44:21 AM
Medicines360 and Camargo Pharmaceutical Services Gain FDA Approval for Intrauterine Contraceptive Device 1/19/2016 6:00:30 AM
Medicines360 Announces New Partnership With Marie Stopes International To Expand Access To Its Hormonal IUD To Women In Kenya, East Africa 12/7/2015 7:49:01 AM
Allergan (AGN) And Medicines360 Announces LILETTA (levonorgestrel-Releasing Intrauterine System) 52 Mg IUS Presented In 3 Abstracts At FIGO 2015 10/6/2015 6:31:34 AM
Medicines360 Names Jessica Grossman As CEO 7/8/2015 11:01:53 AM
Actavis (ACT) And Medicines360 Announce Publication Of ACCESS IUS Efficacy And Safety Study Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 mg in Contraception 4/29/2015 6:32:13 AM
12
//-->